x
Breaking News
More () »

Hospital is first in WNY to offer noninvasive prostate cancer therapy

Performed noninvasively in the outpatient setting under general anesthesia, HIFU uses focal therapy to localize treatment within the prostate gland.

BUFFALO, N.Y. — Buffalo-area hospitals can lay claim to a series of innovations over the last 50 years, ranging from developments that led to the first tests for prostate cancer to new methods for treating blood clots and stroke. Today, the region’s physician researchers and clinicians continue to innovate and come up with new ways to treat disease, develop new devices and equipment and create novel ways to deliver care both inside and outside hospitals. This story is part of a package looking at examples of innovation at some of the largest Western New York health systems.

In 1986, the PSA test for prostate cancer pioneered by a Roswell Park Comprehensive Cancer Center scientist was approved for clinical use by the FDA and is now used worldwide.

Nearly 40 years later, the hospital continues to offer novel tests and treatments for the disease, with the newest treatment providing fewer side effects and better results. High intensity focused ultrasound treatment is administered using advanced robotics, making it a new option for men who previously were candidates only for active surveillance.

Read more from our partners at Buffalo Business First.

Related Video:

Before You Leave, Check This Out